Medical Outreach Program
Medical Outreach Program
Established in 1958, our company’s Medical Outreach Program (MMOP) is the primary mechanism through which our company donates its pharmaceuticals and vaccines for humanitarian assistance in the developing world and in support of disaster relief and emergency situations worldwide.
The program, managed by our Office of Corporate Responsibility, is one mechanism through which we help to expand access to our products, particularly in the developing world. Through this program, we donate critical pharmaceuticals and vaccines to a limited number of qualified, U.S.-based nongovernmental organization (NGO) partners. The scope of the program varies from year to year and is influenced by changing medical needs in developing countries, the quantity of our medicines available for donation, and the random nature of disasters.
Donations of our medicines are made primarily through these qualified NGOs:
Each of these organizations has a long-standing relationship with the company, demonstrates integrity of purpose, provides assurance that our products will be securely warehoused, and has well-established programs for the ill and needy in developing countries. Through the program, we have the ability to monitor the NGOs and to be assured of the proper distribution and handling of our medicines. In addition, we donate only products with adequate dating to ensure proper administration prior to expiry.
Through supply chain and facility assessments of our program partners, we add value beyond our donated medicines. As of October 2016, we had completed collaborative site assessments of all partners’ warehouse facilities to jointly identify improvements in medicine storage and handling to optimize supply chain effectiveness. Recommendations have included such items as regular storage-rack inspection and maintenance, strengthening of delivery receipt procedures, and improvements in material-handling procedures. We continue to collaborate with our partners to address any corrective actions needed to improve the safety, security and storage of our medicines. Future site assessments will be conducted in coordination with our partners as needed.
The MMOP comprises three components:
ANNUAL ALLOTMENT PROGRAM
Through this program, the NGOs with which we work can request medicines of their choice from our company’s current product line, up to an annually authorized amount. Through this approach to donations, our partners can receive a sustained and predictable supply of needed medicines, as is crucial to the effective planning of ongoing humanitarian programs.
ONGOING DONATIONS OF PHARMACEUTICALS & VACCINES
Donations of our pharmaceuticals and vaccines are also made in response to proposals from our partners to address some of the specific needs of their programs around the world. In addition, we offer products to our partners proactively, based on supply, for use in their ongoing humanitarian programs.
DISASTER & EMERGENCY RELIEF
Our disaster relief program is designed to provide assistance in response to major disasters and to support efforts in preparedness and recovery. We may provide donations of medicines and vaccines as well as financial support, where appropriate, through our program partners.
We are a member of the Partnership for Quality Medical Donations (PQMD), an alliance of NGOs and medical product manufacturers dedicated to raising the standards of medical donations in order to meet the needs of underserved populations and disaster victims around the world. We also observe the World Health Organization (WHO) Guidelines for Drug Donations. Both of these efforts help to ensure and maintain the effectiveness of our donation program.
Throughout 2016, the donations of our medicines and vaccines provided disaster assistance in the Dominican Republic, Ecuador, Haiti, and the United States, supported partner medical mission programs, and reached many thousands more worldwide through the ongoing medical programs of the NGOs with which we work.
|Countries and territories reached by the MMOP||92||86||91||72||55|
|People reached by the MMOP1||NA||NA||433,624||78,555||109,398|
|Value of donations of medicines, vaccines and consumer care products (in millions)2,3,4||$86.30||$69.40||$110.20||$31.10||$31.12|
|Disaster relief product contributions (in millions)2||$0.80||$2.40||$8.50||$4.70||$13.41|
|1. Based on converting volume of medicines and vaccines donated in 2016. Conversion factors for this estimate were developed using a combination of QuintilesIMS SMART Data and U.S. product information found on our company’s product website. 2. We set the value of our product donations based on the U.S. wholesale acquisition cost. 3. Figure includes the value of product donations through the MMOP only. 4. Effective October 1, 2014, Bayer AG purchased our company's consumer care business.|